Skip to content

Randomized clinical trial of preoperative localized sublethal hyperthermia on postoperative pain of patients under elective inguinal herniorrhaphy

Effect of preoperative localized sublethal hyperthermia on postoperative pain intensity in patients undergoing elective herniorrhaphy under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015121925600N1
Enrollment
36
Registered
2016-03-08
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia. Unilateral or unspecified Inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: Study group:Warming of operation site, the night before , 1 and 3 hours before surgery, each time for 30 minutes, up to 45 degree of centigrade. Intervention 2: control group:putting w
Treatment - Other
Study group:Warming of operation site, the night before , 1 and 3 hours before surgery, each time for 30 minutes, up to 45 degree of centigrade
control group:putting warming pad on the site of surgery without turning it on, the night before, 1 and 3 hours before surgery each time for 30 minutes.

Sponsors

Vice Chancellor For Research, Urmia University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Male patients ASA I-II scheduled for elective inguinal herniorrhaphy Exclusion criteria:Female gender; age under 20 and above 60 years; ASA physical status >II; history of opioid and non-opioid analgesic or benzodiazepine consumption during seven days before surgery; cardiovascular disease; pulmonary disease; renal disease; hepatic disease; uncontrolled diabetes mellitus; mental disorders; any contraindication for spinal anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 6, 12 and 24 hours after operation. Method of measurement: Visual Analog Scale(VAS).

Secondary

MeasureTime frame
Opioid consumption dose. Timepoint: 6,12 and 24 hours after surgery. Method of measurement: Opioid dose consumption as milligram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Rahman Abbasivash

Urmia University of Medical Sciences

rabbasivash@gmail.com+98 44 3346 8967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026